Intensity Therapeutics

(NASDAQ) INTS

Current Price$4.61

Market Cap$12.51M

Since IPO (2023)-97%

5 YearN/A

1 Year-56%

1 Month-14%

Intensity Therapeutics Financials at a Glance

Market Cap

$12.51M

Revenue (TTM)

$0.00

Net Income (TTM)

$10.69M

EPS (TTM)

$-7.08

P/E Ratio

-0.65

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.61

Volume

304

Open

$4.65

Price

$4.61

Volume

304

Open

$4.65

Previous Close

$4.61

Daily Range

$4.56 - $4.65

52-Week Range

$4.50 - $43.50

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.61

Volume

304

Open

$4.65

Previous Close

$4.61

Daily Range

$4.56 - $4.65

52-Week Range

$4.50 - $43.50

INTS News

Intensity (INTS) Q2 Net Loss Drops 50%

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Intensity Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Lewis H. Bender, MBA

Website

www.intensitytherapeutics.com

Headquarters

Westport, CT 06880, US

INTS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-207%

Return on Capital

-1%

Return on Assets

-87%

Earnings Yield

-1.54%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.51M

Shares Outstanding

2.70M

Volume

304

Avg. Volume

41.61K

Financials (TTM)

Gross Profit

$26.00K

Operating Income

$11.97M

EBITDA

$11.97M

Operating Cash Flow

$9.23M

Capital Expenditure

$0.00

Free Cash Flow

$9.23M

Cash & ST Invst.

$11.92M

Total Debt

$110.00K

Intensity Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$7.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$12.51M

N/A

Market Cap/Employee

$2.50M

N/A

Employees

N/A

Net Income

$2.43M

+27.3%

EBITDA

$2.53M

+25.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$10.14M

+1171.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$70.00K

-31.4%

Short Term Debt

$32.00K

+10.3%

Return on Assets

-87.00%

N/A

Return on Invested Capital

-1.10%

N/A

Free Cash Flow

$1.83M

+8.2%

Operating Cash Flow

$1.83M

+8.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$5.84+11.24%

SONNSonnet BioTherapeutics Holdings, Inc.

SONNSonnet BioTherapeutics Holdings, Inc.$1.26-59.35%

IBIOiBio, Inc.

IBIOiBio, Inc.$1.42-3.40%

ITRMIterum Therapeutics plc

ITRMIterum Therapeutics plc$0.03-10.98%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$9.25-5.03%

PLURPluri Inc.

PLURPluri Inc.$3.12-7.42%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.42-4.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.74-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.20-0.06%

TET1 Energy Inc.

TET1 Energy Inc.$7.00+0.23%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.32-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.54+0.01%

POETPoet Technologies

POETPoet Technologies$14.21-0.11%

FFord Motor Company

FFord Motor Company$13.03-0.03%

Questions About INTS

What is the current price of Intensity Therapeutics?

Intensity Therapeutics is trading at $4.61 per share.

What is the 52-week range for Intensity Therapeutics?

Over the past 52 weeks, Intensity Therapeutics has traded between $4.50 and $43.50.

How much debt does Intensity Therapeutics have?

As of the most recent reporting period, Intensity Therapeutics reported total debt of $102,000.

How much cash does Intensity Therapeutics have on hand?

Intensity Therapeutics reported $10.24M in cash and cash equivalents in its most recent financial results.

What is Intensity Therapeutics’s dividend yield?

Intensity Therapeutics does not currently have a dividend yield.

Intensity Therapeutics

Intensity Therapeutics Financials at a Glance

INTS News

Intensity (INTS) Q2 Net Loss Drops 50%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Intensity Therapeutics

INTS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Intensity Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INTS

What is the current price of Intensity Therapeutics?

What is the 52-week range for Intensity Therapeutics?

How much debt does Intensity Therapeutics have?

How much cash does Intensity Therapeutics have on hand?

What is Intensity Therapeutics’s dividend yield?

Premium Investing Services